Brief: - FDA Grants Clearance For Getinge's Vasoview Hemopro 3
March 8 (Reuters) - Getinge AB GETIb.ST :
* FDA HAS GRANTED 510(K) CLEARANCE FOR VASOVIEW HEMOPRO 3
* IS PREPARING TO LAUNCH VASOVIEW HEMOPRO 3 IN US IN Q3
Source text for Eikon: ID:nWkr66vDDS
Further company coverage: GETIb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Getinge publ AB
See all newsEurope Research Roundup: Akzo Nobel, Handelsbanken, RS Group
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)
Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix
Sweden's Getinge Q3 organic sales rise 2.1%
Brief: Getinge Q3 Adjusted EBITA SEK 1,278 Million